The online pipeline is undergoing construction. Please refer to this PowerPoint for most up-to-date pipeline.

Hit-to-Lead


TB Alliance, University of Auckland
Aston University, University of Birmingham, Tres Cantos GSK
Colorado State University
University of Illinois at Chicago, Myongji University
Lilly TB Drug Discovery Initative
University of Illinois at Chicago
GlaxoSmithKline, TB Alliance
Texas A&M University
Lilly TB Drug Discovery Initiative
TB Alliance, Rutgers University
TB Alliance, Calibr
TB Alliance, Sanofi
SPRINT-TB (National University of Singapore)
SPRINT-TB (National University of Singapore)

Lead Optmization


Kanury Rao, Sundeep Duggar
GlaxoSmithKline, Global Alliance for TB Drug Development
Anacor Pharmaceuticals, GlaxoSmithKline
UNESP/School of Pharmaceutical Sciences
Sequella
Sanofi , TB Alliance
TB Alliance, University of Auckland, Janssen
TB Alliance
GlaxoSmithKline
TB Alliance/Yonsei University
SPRINT-TB (National University of Singapore)
SPRINT-TB (National University of Singapore)
SPRINT-TB (National University of Singapore)
TB Alliance, Sanofi
TB Alliance, Calibr

Pre-Clinical (Non-GLP)


St Jude Children's Research Hospital, University of Tennessee Health Science Center, Colorado State University, University of Zurich, Microbiotix
TB Alliance, Sanofi
Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan, Lilly TB Drug Discovery Initiative, NIAID, IDRI, Lilly, YourEncore
Institute of Materia Medica